Korean Circ J.  2021 Oct;51(10):863-865. 10.4070/kcj.2021.0275.

QTc Dispersion Predicts Prognosis in COVID-19 Disease

• Jang SW

• KMID: 2520694
• DOI: http://doi.org/10.4070/kcj.2021.0275

Reference

1. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med. 2020; 382:2372–2374. PMID: 32302078.

2. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–1069. PMID: 32031570.

3. Kim IC, Kim HA, Park JS, Nam CW. Updates of cardiovascular manifestations in COVID-19: Korean experience to broaden worldwide perspectives. Korean Circ J. 2020; 50:543–554. PMID: 32588565.

4. Rubin GA, Desai AD, Chai Z, et al. Cardiac corrected QT interval changes among patients treated for COVID-19 infection during the early phase of the pandemic. JAMA Netw Open. 2021; 4:e216842. PMID: 33890991.

5. Tse G, Yeo JM, Chan YW, Lai ET, Yan BP. What is the arrhythmic substrate in viral myocarditis? Insights from clinical and animal studies. Front Physiol. 2016; 7:308. PMID: 27493633.

6. Etheridge SP, Asaki SY. COVID-19 infection and corrected QT interval prolongation-collateral damage from our newest enemy. JAMA Netw Open. 2021; 4:e217192. PMID: 33890995.

7. Bae HJ, Cho HJ, Lee CH, et al. Electrocardiographic manifestations in patients with COVID-19: Daegu in South Korea. Korean Circ J. 2021; 51:851–862.

8. Akhtar Z, Gallagher MM, Yap YG, et al. Prolonged QT predicts prognosis in COVID-19. Pacing Clin Electrophysiol. 2021; 44:875–882. PMID: 33792080.

9. Jiménez-Jáimez J, Macías-Ruiz R, Bermúdez-Jiménez F, et al. Absence of relevant QT interval prolongation in not critically ill COVID-19 patients. Sci Rep. 2020; 10:21417. PMID: 33293554.

10. Changal K, Paternite D, Mack S, et al. Coronavirus disease 2019 (COVID-19) and QTc prolongation. BMC Cardiovasc Disord. 2021; 21:158. PMID: 33784966.